Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces
- PMID: 20593492
- DOI: 10.1002/path.2719
Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces
Abstract
The success of pregnancy is a result of countless ongoing interactions between the placenta and the maternal immune and cardiovascular systems. Pre-eclampsia is a serious pregnancy complication that arises from multiple potential aberrations in these systems. The pathophysiology of pre-eclampsia is established in the first trimester of pregnancy, when a range of deficiencies in placentation affect the key process of spiral artery remodelling. As pregnancy progresses to the third trimester, inadequate spiral artery remodelling along with multiple haemodynamic, placental and maternal factors converge to activate the maternal immune and cardiovascular systems, events which may in part result from increased shedding of placental debris. As we understand more about the pathophysiology of pre-eclampsia, it is becoming clear that the development of early- and late-onset pre-eclampsia, as well as intrauterine growth restriction (IUGR), does not necessarily arise from the same underlying pathology.
Similar articles
-
The origins and end-organ consequence of pre-eclampsia.Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):435-47. doi: 10.1016/j.bpobgyn.2011.01.005. Epub 2011 Mar 1. Best Pract Res Clin Obstet Gynaecol. 2011. PMID: 21367667 Review.
-
Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health.Clin Exp Pharmacol Physiol. 2006 Sep;33(9):826-30. doi: 10.1111/j.1440-1681.2006.04448.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16922815 Review.
-
Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia.Am J Obstet Gynecol. 2006 Jul;195(1):40-9. doi: 10.1016/j.ajog.2005.07.049. Epub 2006 Apr 21. Am J Obstet Gynecol. 2006. PMID: 16813742 Review.
-
Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction.Placenta. 2006 Jan;27(1):56-61. doi: 10.1016/j.placenta.2004.11.007. Epub 2005 Jan 25. Placenta. 2006. PMID: 16310038
-
Developmental biology of the placenta and the origins of placental insufficiency.Semin Fetal Neonatal Med. 2004 Oct;9(5):357-69. doi: 10.1016/j.siny.2004.03.006. Semin Fetal Neonatal Med. 2004. PMID: 15691771 Review.
Cited by
-
Soyghurt Potentially Controls the Level of sFlt1 and PLGF in Preeclampsia Maternal Serum-Induced Placental Trophoblast Cell in vitro.J Exp Pharmacol. 2024 Mar 13;16:111-122. doi: 10.2147/JEP.S446961. eCollection 2024. J Exp Pharmacol. 2024. PMID: 38504909 Free PMC article.
-
A Comprehensive Analysis of Organic Food: Evaluating Nutritional Value and Impact on Human Health.Foods. 2024 Jan 9;13(2):208. doi: 10.3390/foods13020208. Foods. 2024. PMID: 38254509 Free PMC article. Review.
-
Evaluation of the Effect of Vitamin D Levels During the Last Trimester of Pregnancy on Fetomaternal Outcomes in Patients With Preeclampsia.Cureus. 2023 Nov 20;15(11):e49145. doi: 10.7759/cureus.49145. eCollection 2023 Nov. Cureus. 2023. PMID: 38130538 Free PMC article.
-
A Review on Inflammasomes and Immune Checkpoints in Pre-Eclampsia Complicated with Tuberculosis and Human Immune Deficiency Virus.Int J Environ Res Public Health. 2023 Aug 22;20(17):6627. doi: 10.3390/ijerph20176627. Int J Environ Res Public Health. 2023. PMID: 37681767 Free PMC article. Review.
-
Soluble Vascular Adhesion Protein 1 (sVAP-1) as a biomarker for pregnancy complications: A pilot study.PLoS One. 2023 May 30;18(5):e0284412. doi: 10.1371/journal.pone.0284412. eCollection 2023. PLoS One. 2023. PMID: 37253043 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
